Showing results (951-960 of 14,088) with videos related to
Sort By:
Pageof 1,409
Gynecologic Oncology|October 1, 1983
The postoperative classification for uterine cervical cancer and its clinical evaluationH Noguchi, K Shiozawa, T Tsukamoto, et al.Gynecologic Oncology|October 1, 1983
Circulating IgG-specific immune complexes as a potential tumor marker in gynecological malignanciesJ K Dodd, L J Hicks, J P Tyler, et al.Gynecologic Oncology|October 1, 1983
Cryosurgical treatment of cervical intraepithelial neoplasia (CIN III) in 102 patientsM van Lent, J B Trimbos, A P Heintz, et al.Gynecologic Oncology|October 1, 1983
The role of radioactive colloids in malignant peritoneal mesotheliomasJ Cain, D Nori, A Huvos, et al.Gynecologic Oncology|October 1, 1983
Dermatofibrosarcoma protuberans of the vulvaR Agress, D C Figge, H Tamimi, et al.Gynecologic Oncology|May 1, 1984
Phase II and pharmacokinetic study of high-dose methotrexate in the treatment of advanced gynecologic malignancy. A Southwest Oncology Group TrialR D Hilgers, D S Alberts, J C Standefer, et al.Gynecologic Oncology|November 1, 1993
Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervixM Höckel, B Vorndran, K Schlenger, et al.Gynecologic Oncology|November 1, 1993
Papillary serous carcinoma of the peritoneal surface: matched-case comparison with papillary serous ovarian carcinomaM A Killackey, A R DavisGynecologic Oncology|November 1, 1993
Whole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose can detect recurrent ovarian carcinomaB Y Karlan, R Hawkins, C Hoh, et al.Gynecologic Oncology|November 1, 1993
Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG)K F Hubner, T W McDonald, J G Niethammer, et al.Pageof 1,409